K-numberK252018
Device nameHERA Z20 Diagnostic Ultrasound System; HERA Z20e Diagnostic Ultrasound System; HERA Z20s Diagnostic Ultrasound System; R20 Diagnostic Ultrasound System; HERA Z30 Diagnostic Ultrasound System; R30 Diagnostic Ultrasound System
ApplicantSamsung Medison Co., Ltd.
Product codeIYN
Device classClass II
Decision dateJan 5, 2026
DecisionSubstantially Equivalent
Regulation892.1550
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The HERA Z20/Z20e/Z20s, R20, HERA Z30, and R30 are general-purpose, mobile diagnostic ultrasound systems that acquire and display 2D, Doppler, M-mode, and 3D/4D ultrasound images for clinical diagnosis across fetal/obstetric, abdominal, cardiac, musculoskeletal, and other applications. They are intended for use by qualified healthcare professionals in hospitals, clinics, and private practices.

Technological characteristics

The proposed devices employ the same fundamental ultrasound imaging technology as the primary predicate (HERA Z20/R20/HERA Z30/R30, K241971). Key differences include: addition of ophthalmic clinical application; new AI/ML-based software features (AbdomenAssist, BladderAssist, QualityCheck, PelvicAssist); migrated and updated features from secondary predicate (NerveTrack detection, EzVolume, UterineAssist); 11 new transducers; expanded EzStructure and AutoEF applications; and software enhancements to CEUS+. All systems have identical imaging modes, measurement capabilities, and real-time acoustic output displays.

Test standards cited

IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, IEC 60601-4-2, ISO 10993-1, ISO 14971, NEMA UD 2-2004. Testing included acoustic output, biocompatibility, software function, electrical safety, electromagnetic compatibility, thermal and mechanical safety, and cleaning/disinfection effectiveness.

Substantial equivalence argument

Substantial equivalence is established because the proposed devices have the same clinical intended use, identical imaging modes and capabilities, and employ the same fundamental ultrasound technology as the primary predicate. AI/ML features and new transducers are incremental enhancements; their safety and effectiveness are supported by non-clinical testing, algorithm validation on large datasets (40–43,000+ images), and compliance with applicable safety standards. The systems maintain equivalent measurement, imaging, and reporting functionality with no new safety concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →